CRP and atherosclerosis: In 2005 a statin therapy trial comparing moderate statin therapy (40 mg pravastatin daily) and intensive statin therapy (80 mg atorvastatin daily) for patients with CHD showed that a decrease in CRP levels during statin treatment independently and significantly correlates with progression of atherosclerosis [35].